Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Rowland

Showing results (161-170 of 184) with videos related to

Pageof 19
Sort By:
British Journal of Clinical Pharmacology|October 20, 2018
Plasma extracellular nanovesicle (exosome)-derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposureAndrew Rowland, Warit Ruanglertboon, Madelé van Dyk, et al.
Clinical Trials (London, England)|October 16, 2024
The state of individual participant data sharing for the highest-revenue medicinesNatansh D Modi, Lee X Li, Jessica M Logan, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 27, 2016
Kinase inhibitor pharmacokinetics: comprehensive summary and roadmap for addressing inter-individual variability in exposureAndrew Rowland, Madelé van Dyk, Arduino A Mangoni, et al.
NPJ Breast Cancer|March 23, 2021
The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial dataNatansh D Modi, Jin Quan Eugene Tan, Andrew Rowland, et al.
Proteomics|December 1, 2023
Proteomic profiling of paired human liver homogenate and tissue derived extracellular vesiclesZivile Useckaite, Lauren A Newman, Ashley M Hopkins, et al.
Targeted Oncology|January 8, 2025
Tumour Mutational Burden and Immune Checkpoint Inhibitor Response in Non-small Cell Lung Cancer: A Continuous Modelling ApproachMichael J Sorich, Arkady T Manning-Bennett, Lee X Li, et al.
Clinical Pharmacology and Therapeutics|April 1, 2021
Exploring the Use of Serum-Derived Small Extracellular Vesicles as Liquid Biopsy to Study the Induction of Hepatic Cytochromes P450 and Organic Anion Transporting PolypeptidesA David Rodrigues, Madelé van Dyk, Michael J Sorich, et al.
Public Health Reports (Washington, D.C. : 1974)|February 26, 2026
Evaluation of Generative Artificial Intelligence Safeguards Against the Creation of Images and Videos Harmful to Public HealthBianca Chu, Natansh D Modi, Bradley D Menz, et al.
Annals of Internal Medicine|June 23, 2025
Assessing the System-Instruction Vulnerabilities of Large Language Models to Malicious Conversion Into Health Disinformation ChatbotsNatansh D Modi, Bradley D Menz, Abdulhalim A Awaty, et al.
JAMA Oncology|July 28, 2022
Audit of Data Sharing by Pharmaceutical Companies for Anticancer Medicines Approved by the US Food and Drug AdministrationNatansh D Modi, Ahmad Y Abuhelwa, Ross A McKinnon, et al.
Pageof 19

Showing results (161-170 of 184) with videos related to

Sort By:
Pageof 19
British Journal of Clinical Pharmacology|October 20, 2018
Plasma extracellular nanovesicle (exosome)-derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposureAndrew Rowland, Warit Ruanglertboon, Madelé van Dyk, et al.
Clinical Trials (London, England)|October 16, 2024
The state of individual participant data sharing for the highest-revenue medicinesNatansh D Modi, Lee X Li, Jessica M Logan, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 27, 2016
Kinase inhibitor pharmacokinetics: comprehensive summary and roadmap for addressing inter-individual variability in exposureAndrew Rowland, Madelé van Dyk, Arduino A Mangoni, et al.
NPJ Breast Cancer|March 23, 2021
The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial dataNatansh D Modi, Jin Quan Eugene Tan, Andrew Rowland, et al.
Proteomics|December 1, 2023
Proteomic profiling of paired human liver homogenate and tissue derived extracellular vesiclesZivile Useckaite, Lauren A Newman, Ashley M Hopkins, et al.
Targeted Oncology|January 8, 2025
Tumour Mutational Burden and Immune Checkpoint Inhibitor Response in Non-small Cell Lung Cancer: A Continuous Modelling ApproachMichael J Sorich, Arkady T Manning-Bennett, Lee X Li, et al.
Clinical Pharmacology and Therapeutics|April 1, 2021
Exploring the Use of Serum-Derived Small Extracellular Vesicles as Liquid Biopsy to Study the Induction of Hepatic Cytochromes P450 and Organic Anion Transporting PolypeptidesA David Rodrigues, Madelé van Dyk, Michael J Sorich, et al.
Public Health Reports (Washington, D.C. : 1974)|February 26, 2026
Evaluation of Generative Artificial Intelligence Safeguards Against the Creation of Images and Videos Harmful to Public HealthBianca Chu, Natansh D Modi, Bradley D Menz, et al.
Annals of Internal Medicine|June 23, 2025
Assessing the System-Instruction Vulnerabilities of Large Language Models to Malicious Conversion Into Health Disinformation ChatbotsNatansh D Modi, Bradley D Menz, Abdulhalim A Awaty, et al.
JAMA Oncology|July 28, 2022
Audit of Data Sharing by Pharmaceutical Companies for Anticancer Medicines Approved by the US Food and Drug AdministrationNatansh D Modi, Ahmad Y Abuhelwa, Ross A McKinnon, et al.
Pageof 19